Symbiosis control

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 12.09.2026

Dieser Artikel auf Deutsch

Synonym(s)

Microbiological therapy

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

Definition This section has been translated automatically.

Therapy to restore or maintain the normal germ flora of the intestine, see also under Microbiological therapy.

Indication This section has been translated automatically.

Dysbiosis of various origins, e.g., following antibiotic use, malnutrition, or intestinal infections. In addition to bloating and flatulence, dysbiosis can lead to Roemheld syndrome. Ammonia exposure affects brain metabolism, leading to fatigue and decreased performance. Indoles and phenols, as well as fusel alcohols produced by dysbiosis, place a strain on liver metabolism. Immunological effects lead to a worsening of conditions such as atopic eczema, bronchial asthma, hay fever, ulcerative colitis, Crohn’s disease, chronic gastritis, and gingivitis.

Implementation This section has been translated automatically.

The symbiosis control should be carried out in three phases, extending over 12 weeks in total. Fungal infestation should be excluded or treated in advance.
  • 1st phase: Reduction of the defective intestinal flora: magnesium peroxide, e.g. Ozovit.
  • 2nd phase: stimulation of the excretory digestive organs: bitter substances, lactose (marrow act) and camomile extract.
  • 3rd phase: colonisation of apathogenic E. coli strains, e.g. Symbioflor 2, Mutaflor.

Authors

Last updated on: 12.09.2026